Yeoh E K, Spittle M F
Clin Radiol. 1986 Mar;37(2):165-8. doi: 10.1016/s0009-9260(86)80391-9.
This study reports on 5 years experience of the treatment of carcinoma of the cervix and poor-risk carcinoma of the body of the uterus using a combination of external beam radiotherapy and high-dose-rate intracavitary 60Co-brachytherapy using the Cathetron since 1979 at the Middlesex Hospital, London. Despite a reduction in external beam dose of 20% since 1979, survival rates for both diseases remain unchanged and also compare favourably with those of other centres; they are 70.02% for carcinoma of the cervix of all stages except Ia, and 81.17% for 'poor-risk' carcinoma of body of uterus of all stages. The complication rates were acceptable. Analysis of the results of treatment by stage of disease in those patients with carcinoma of the cervix revealed that, except for Stage I cases, the results were comparable with those reported in the literature. The reason for the poor results in Stage I was found to be due to the high proportion of patients of 35 years of age and under with Stage I disease who fared significantly worse than older patients.
本研究报告了自1979年起在伦敦米德尔塞克斯医院使用体外照射放疗与使用卡特隆后装技术进行高剂量率腔内60钴近距离放疗相结合的方法治疗宫颈癌及子宫体低危癌的5年经验。尽管自1979年以来体外照射剂量降低了20%,但两种疾病的生存率均保持不变,且与其他中心相比也更具优势;除Ia期外的各期宫颈癌生存率为70.02%,各期子宫体“低危”癌生存率为81.17%。并发症发生率是可以接受的。对宫颈癌患者按疾病分期进行治疗结果分析发现,除I期病例外,结果与文献报道相当。I期结果较差的原因是该期35岁及以下患者比例较高,其预后明显比老年患者差。